Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular Carcinoma [Phase 1]
This update describes a Phase 1 trial of QL1706 as second-line therapy for advanced hepatocellular carcinoma; the study is not yet recruitin…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Amplitude-modulated Radiofrequency Electromagnetic Field Treatment for Advanced Hepatocellular Carcinoma (Immune-RF) [NA]
An ongoing clinical trial evaluating amplitude-modulated radiofrequency electromagnetic field treatment (Immune-RF) for advanced hepatocellu…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC
This entry reports a prospective multicenter Phase II clinical study evaluating DEB-TACE combined with SALOX-HAIC for unresectable advanced …
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Cryoablation and Arterial Infusion of SD-101 in Combination with Durvalumab and Tremelimumab [Phase 1]
Phase 1 trial evaluating cryoablation and arterial infusion of SD-101 with durvalumab and tremelimumab for hepatocellular carcinoma. Recruit…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Lenvatinib Combined with Tislelizumab and TACE Applied As Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma with High-risk Recurrence Factors [Phase 2]
This clinical trial update describes a Phase 2 neoadjuvant regimen for CNLC stage IB/IIA hepatocellular carcinoma with high-risk recurrence …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing
This clinical trial update describes an Ambispective Cohort Study using next-generation sequencing-guided precision medicine for primary hep…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT [NA]
A clinical trial is evaluating a combination of transarterial chemoembolization (TACE) with atezolizumab/bevacizumab and I-125 seed brachyth…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Camrelizumab Combined with Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) As Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC) [Phase 2, Phase 3]
A Phase 2/3 trial evaluating camrelizumab in combination with rivoceranib and hepatic arterial infusion chemotherapy as conversion therapy f…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Study on the Classification of Comprehensive Treatment Effect of Hepatocellular Carcinoma [NA]
This clinical trial update outlines a study to classify the comprehensive treatment effects in hepatocellular carcinoma, with a focus on pat…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: The Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Hepatocellular Carcinoma [NA]
A clinical trial is investigating nutrition-optimized prehabilitation to improve perioperative outcomes in patients with hepatocellular carc…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers
This clinical trial update notes that an early-stage detection study for liver cancer, biliary tract cancer, and pancreatic cancer is curren…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: Study of Durvalumab Plus Tremelimumab as First-line Treatment in Chinese Patients With Unresectable Hepatocellular Carinoma [Phase 3]
A Phase 3 clinical trial evaluating first-line durvalumab plus tremelimumab in Chinese patients with unresectable hepatocellular carcinoma i…
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence [Phase 2]
This Phase 2 trial investigates perioperative use of hepatic arterial infusion chemotherapy combined with donafenib and sintilimab for patie…
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma
This clinical trial, sponsored by Sun Yat-sen University, is recruiting to evaluate HAIC combined with lenvatinib and a PD-1 inhibitor for i…
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation [NA]
A clinical trial evaluating bariatric embolization of arteries in obese patients with hepatocellular carcinoma to enable salvage liver trans…
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma
This clinical trial update reports on real-life use of atezolizumab-bevacizumab and other immunotherapies for hepatocellular carcinoma; the …
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: Sarcopenia and Systemic Therapy in HCC
A trial titled 'Sarcopenia and Systemic Therapy in Hepatocellular Carcinoma' conducted by IRCCS Azienda Ospedaliero-Universitaria di Bologna…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Fusing Ultrasound and Magnetic Resonance Imaging to Intelligently Plan Highly Conformal Ablation Thermal Field for Hepatocellular Carcinoma
This clinical trial update describes a fused ultrasound and magnetic resonance imaging approach to plan highly conformal ablation therapy fo…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT [Phase 3]
Phase 3 trial comparing lenvatinib plus DEB-TACE with HAIC versus lenvatinib plus DEB-TACE in patients with large hepatocellular carcinoma a…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Y-90 SIRT for Unresectable HCC Larger Than 7cm [Phase 2]
A Phase 2 clinical trial evaluating yttrium-90 selective internal radiation therapy for unresectable hepatocellular carcinoma larger than 7 …
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint Inhibitors
This is a prospective cohort study evaluating immune checkpoint inhibitors in hepatobiliary cancers. The trial is currently active but not r…
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma [Phase 1]
Phase 1 trial of BPI-371153 in advanced solid tumors and lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: Ga-68 Dolacga PET Scan in HCC Under RFA
A National Taiwan University Hospital trial is evaluating Ga-68 Dolacga PET imaging for hepatocellular carcinoma under radiofrequency ablati…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov entry for a prospective study collecting efficacy and safety data in patients with unresectable hepatocellular carcinoma.…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: An Organoid-on-chips Technique Based on Biopsy Samples and Its Efficacy in Predicting the Response to HAI in HCC
This clinical trial update describes an organoid-on-a-chip system derived from biopsy samples and its potential to predict response to hepat…